The Official CORMEDIX (CRMD)thread (run up to FDA approval has begun )

[Tug life]

I have to learn to be patient with this stock stuff, after reading your post yesterday sold half my shares since we were up lol, looks like today gonna be a good day

We have a little while before we meet with the FDA again and a NDA probably won't be completed and accepted until later this year. Partnership speculation will probably drive the price up at some point but other than that we have a while before some significant news so you'll probably have a chance to buy back in lower.


Also our own Dr.Phoebe Mounts is doing a presentation at a FDA meeting this friday.

 

[Tug life]

that's not good is it??? Side note I sold my $Nept today... shyt constantly has gone down in months literally...

This post certainly didn't age well. Up 15% since then

 

[ORDER_66]

This post certainly didn't age well. Up 15% since then

I needed the money...:trollol:

 

[Tug life]

Amarin Announces $400,000,000 Public Offering of American Depositary Shares @KING WILL people are saying this means they are going it alone and a buyout is not gonna happen plus more dilution of the stock. This is crashing hard

 

[KING WILL]

Amarin Announces $400,000,000 Public Offering of American Depositary Shares @KING WILL people are saying this means they are going it alone and a buyout is not gonna happen plus more dilution of the stock. This is crashing hard

Yea, a lot of shareholders been waiting to GIA. Its gonna mean more value long term. It sucks for me short term, cuz I wanted a quick BO, then make my moves from there. But, the science behind the Drug still stands. Just pushes my protentional retirement date back a few years.

 

[broller]

Amarin Announces $400,000,000 Public Offering of American Depositary Shares @KING WILL people are saying this means they are going it alone and a buyout is not gonna happen plus more dilution of the stock. This is crashing hard

where do you think it'll land?

i feel long-term this will help and i might buy more on the dip

 

[Tug life]

where do you think it'll land?

i feel long-term this will help and i might buy more on the dip

I thinks shorts will attack this until there is some significantly good news. Looks like we are headed back to the $17 range shorts aren't done with this yet. Earnings report coming up so maybe some kind of boost can come from it

 

[Starski]

I thinks shorts will attack this until there is some significantly good news. Looks like we are headed back to the $17 range shorts aren't done with this yet. Earnings report coming up so maybe some kind of boost can come from it

Will be in the sun $20 range for a while

Watchlist this week:

$heb
$Aray
$snes
$Roan

Edit: adding AQB, AWSM,

 

[KING WILL]

Amarin Announces $400,000,000 Public Offering of American Depositary Shares @KING WILL people are saying this means they are going it alone and a buyout is not gonna happen plus more dilution of the stock. This is crashing hard

Is a buyout really off the table?
A buyout is definitely not off the table. If anything, this capital raise removed any leverage potential buyers had in negotiations -- in effect, that Amarin didn't have the financial resources to realize Vascepa's full commercial potential. Amarin, in kind, can now demand top dollar for its hand or simply brush off these overtures from potential suitors. In the breath, a buyout probably isn't even in the best interests of long-term shareholders at this stage.

Amarin's shareholders would arguably be better served by a co-promotional deal in the same vein as Pfizer's agreement with cancer diagnostic specialist Exact Sciences . Such a deal would greatly bolster Vascepa's commercial reach through Pfizer's vast network, and perhaps entail an in-licensing deal of one or more of the pharma giant's early stage candidates. In that way, Amarin would be able to both capitalize on Vascepa's monstrous commercial potential and create deep value for its shareholders at the same time.

The key takeaway here is that investors shouldn't sweat this capital raise. Amarin has proven to be a winning play for biopharma investors and this capital raise only creates more avenues for value creation in the years to come. Lastly, there's no reason to believe that a capital raise has any bearing on possible buyout talks -- other than the fact that Amarin would now be negotiating from a position of strength.


Amarin: Is a Buyout Really Off the Table?

 

[jaguar paw]

Just hit 100 shares of Amarin

 

[Neuromancer]

Just hit 100 shares of Amarin

Is this a good buy?

 

[Tug life]

KPTI Karyopharm Therapeutics — Stock Price and Discussion | StockTwits

i think i'm gonna start fukking heavy with KPTI

Good ass pick bro KPTI is up around 40% since this post. It was at like $5.66 and reached a high of $10.60 and now it's at $8.81. That was a great idea

 

[broller]

Good ass pick bro KPTI is up around 40% since this post. It was at like $5.66 and reached a high of $10.60 and now it's at $8.81. That was a great idea

thanks breh. i wish i had gone even heavier but i'm still happy with my decision.

i hope amrn rebounds.

 

[jaguar paw]

Is this a good buy?

Do your own research on it.

 

[KING WILL]

Rivaroxaban (Xarelto) added to aspirin and icosapent ethyl (Vascepa) added to standard prevention therapies are of at least modest net clinical benefit and cost-effective, according to a preliminary report from the Institute for Clinical and Economic Review (ICER).

Both drugs got a B+ rating for higher risk patients from the non-profit, in a draft evidence report to be voted on by the organization's independent voting council of clinicians, patients, and health services researchers on Sept. 26. The document is open for public comment until Aug. 20 and will be finalized Sept. 12.


ICER: Vascepa, Xarelto Cost-Effective in CVD Prevention




ICER's Report released today.